$195.07 +$0.47 (+0.24%)
休市 · Nov 7, 9:10 am ET · 最新盘后价 $195.07 0.00%
开盘$194.53
昨收$194.60
当日区间$194.40 – $195.25
成交量1.35M
市值$21.19B
市盈率（TTM）21.8
股息率–
PTC 相关新闻
匹配 PTC Inc 或代码 PTC 的头条新闻，按最新排序。
- KeyBanc Maintains PTC Inc(PTC.US) With Buy Rating
- Cantor Fitzgerald Maintains PTC Therapeutics(PTCT.US) With Buy Rating, Raises Target Price to $137 正面
- Wells Fargo Maintains PTC Therapeutics(PTCT.US) With Buy Rating, Maintains Target Price $109
- PTC Insiders Sold US$9.1m Of Shares Suggesting Hesitancy
- Barclays Maintains PTC Therapeutics(PTCT.US) With Buy Rating, Maintains Target Price $120
- Berenberg Bank Maintains PTC Inc(PTC.US) With Hold Rating, Maintains Target Price $170
- TD Cowen Maintains PTC Therapeutics(PTCT.US) With Buy Rating, Maintains Target Price $90
- Barclays Maintains PTC Therapeutics(PTCT.US) With Buy Rating, Raises Target Price to $122 正面
- Cantor Fitzgerald Maintains PTC Therapeutics(PTCT.US) With Buy Rating, Maintains Target Price $130
- Wells Fargo Maintains PTC Therapeutics(PTCT.US) With Buy Rating, Raises Target Price to $109 正面
- BofA Securities Maintains PTC Therapeutics(PTCT.US) With Buy Rating, Maintains Target Price $96
- Goldman Sachs Maintains PTC Therapeutics(PTCT.US) With Sell Rating, Raises Target Price to $70 正面
- A Quick Look at Today's Ratings for PTC Inc(PTC.US), With a Forecast Between $141 to $205
- Wells Fargo Maintains PTC Therapeutics(PTCT.US) With Buy Rating, Maintains Target Price $106
- Citi Maintains PTC Inc(PTC.US) With Hold Rating, Raises Target Price to $141 正面
暂无评论——快来第一个聊聊 PTC。
登录后参与讨论。